Home » RXi Pharmaceuticals, Mirna Therapeutics Form Research Collaboration
RXi Pharmaceuticals, Mirna Therapeutics Form Research Collaboration
RXi Pharmaceuticals Corp., a biopharmaceutical company pursuing the
development and commercialization of proprietary therapeutics based on RNA interference, said that it has entered into a research collaboration with Mirna
Therapeutics to determine the utility of combining RXi’s proprietary rxRNA technology
with Mirna’s microRNA mimics as potential therapeutics in oncology.
TradingMarkets
TradingMarkets
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May